The equity rights in NeuroVive Pharmaceutical AB will be delisted. Last day of
trading will be June 28, 2017.
Instrument Equity Rights --------------------------- Short name NVP TO 3 --------------------------- ISIN code SE0008213094 --------------------------- Orderbook ID 122899 ---------------------------
For further information concerning this exchange notice please call Elin Nygren or Caroline Folke, telephone +46 8 405 60 00, or iss@nasdaq.com .
Instrument Equity Rights --------------------------- Short name NVP TO 3 --------------------------- ISIN code SE0008213094 --------------------------- Orderbook ID 122899 ---------------------------
For further information concerning this exchange notice please call Elin Nygren or Caroline Folke, telephone +46 8 405 60 00, or iss@nasdaq.com .